Nasal spray vs. needle: new study tests easier allergy rescue

NCT ID NCT06834165

Recruiting now Symptom relief Sponsor: ARS Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the safety of a nasal spray called neffy compared to a standard epinephrine shot for treating allergic reactions. It involves 600 people aged 4 and older who have an allergic reaction during a food challenge or allergy shot session. The goal is to see if the spray works as well and is as safe as the injection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease hypersensitivity reaction disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLERGIC REACTIONS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Children's National Hospital
RECRUITING

Washington D.C., District of Columbia, 20010, United States

Contact
Cincinnati Children's Hospital Medical Center
RECRUITING

Cincinnati, Ohio, 45229, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Endeavor Health
RECRUITING

Glenview, Illinois, 60026, United States

Contact
Orso Health, Inc.
RECRUITING

La Jolla, California, 92037, United States

Contact

Contact
University Of Michigan
RECRUITING

Ann Arbor, Michigan, 48105, United States

Contact
Weill Cornell Medicine/NewYork Presbyterian Hospital
RECRUITING

New York, New York, 10021, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.